Buy, Sell, or Hold: CoreWeave at $100

Buy, Sell, or Hold: CoreWeave at $100 Gorodenkoff / Shutterstock.com Vandita Jadeja Mon, June 8, 2026 at 9:15 PM GMT+7 5 min read CRWV NVDA Quick Read CRWV is rated Hold after a 27% drop despite 112% revenue growth and a $99 billion contracted backlog. Top insiders sold nearly $300 million in shares during the drawdown, while total liabilities hit $51 billion against just $5 billion in equity. CFO Nitin Agrawal called Q1 the margin trough, but Q2 guidance leaves virtually no buffer against $700 million in interest expense. Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and CoreWeave, Inc. Class A Common Stock didn t make the cut. Grab the names FREE today. At $100.39, CoreWeave (NASDAQ:CRWV) is a hold. The stock has shed 27.24% in a month while investors debate a core question: can the company convert a $99.4 billion backlog into cash before the debt math turns ugly. CoreWeave operates a specialized GPU cloud for AI training and inference, positioned between hyperscalers like Microsoft and Meta and NVIDIA silicon. Its $2.078 billion Q1 revenue, up 111.69% year over year, beat estimates by 5.80%, yet the stock has slid from $136.80 at the filing to triple digits as investors weigh the capital intensity behind that growth. Revenue backlog reached $99.4 billion, near 4x year over year, after Q1 bookings of more than $40 billion including a $21 billion Meta commitment and a multi-year Anthropic deal. CEO Mike Intrator says "the world s four preeminent AI model developers now rely on CoreWeave Cloud as do nine of the ten AI leaders outside of China." Management reaffirmed $12 billion to $13 billion of 2026 revenue and raised the low end of exit-2026 annualized run rate to $18 billion to $19 billion, with a path to more than $30 billion exiting 2027. NVIDIA s $2 billion equity check and Exemplar Cloud status validate the moat. With shares 25.66% off year-ago levels, the entry looks cheap against a five-year contracted revenue profile. Q1 net loss widened to $740 million from $315 million, interest expense doubled to $536 million, and total liabilities sit at $50.81 billion against $4.76 billion of equity. Free cash flow ran negative $4.71 billion as CapEx ballooned to $7.7 billion in a single quarter. Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and CoreWeave, Inc. Class A Common Stock didn t make the cut. Grab the names FREE today. Insiders have been selling. CEO Intrator sold roughly $100 million across May and June, CSO Brian Venturo offloaded near $90 million, and Director Jack Cogen disposed of about $107 million. That is a striking signal during a 27.24% drawdown, and Morningstar warns the stock trades "just above its fair value estimate." CFO Nitin Agrawal told analysts "Q1 was the trough of our margin story" with sequential expansion expected as deployments cross the three-month fit-out window. Adjusted operating margin should return to low double digits by Q4. That is the bull case in waiting and the bear s trap door if Q2 or Q3 disappoints. Q2 guidance of $2.45 billion to $2.6 billion in revenue with adjusted operating income of just $30 million to $90 million against $650 million to $730 million of interest expense leaves no room for slippage. The next two earnings reports will reveal whether contribution margins normalize as promised. CoreWeave trades at $100.39 against an analyst consensus target of $140.18, implying 39.64% upside. Coverage is wide: 3 Strong Buy, 19 Buy, 11 Hold, 1 Sell, and 1 Strong Sell. Year to date, CRWV is up 40.19% versus the S&P 500 s 8.16%, yet shares trade below the $105.98 50-day moving average and at 8.8x sales with a $54.77 billion market cap and negative trailing EPS of -$2.72. At $100, CoreWeave s risk/reward looks balanced. The Buy case requires faith that margin expansion arrives on schedule. The Sell case requires belief that the AI capex cycle cracks before backlog converts. Both hinge on data still ahead. Q2 results, due in roughly two months, will deliver the first real test of "sequential expansion through the balance of the year." A clean beat with operating income at the high end of $30 million to $90 million, plus evidence that contribution margins normalize toward mid-20s, flips this to a Buy with conviction. A miss, especially one driven by deployment delays referenced in the pending securities fraud action, opens a path back toward the $63.80 52-week low as the market reprices the gap between $50.81 billion of liabilities and a still-unprofitable P&L. The cost of waiting is roughly 39.64% of theoretical upside; the cost of acting early is owning a leveraged AI build-out through a guidance reset. With a backlog this large, debt this heavy, and insiders this active on the sell side, let the next earnings report settle the argument. Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and CoreWeave, Inc. Class A Common Stock didn t make the cu

Buy, Sell, or Hold: CoreWeave at $100

Key takeaways

More in business